- Home
- LRMR vs SOPH Comparison
LRMR vs SOPH Comparison
Compare LRMR & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- SOPH
- Stock Information
- Founded
- LRMR N/A
- SOPH 2011
- Country
- LRMR United States
- SOPH Switzerland
- Employees
- LRMR N/A
- SOPH N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LRMR Health Care
- SOPH Health Care
- Exchange
- LRMR Nasdaq
- SOPH Nasdaq
- Market Cap
- LRMR 183.8M
- SOPH 206.6M
- IPO Year
- LRMR N/A
- SOPH 2021
- Fundamental
- Price
- LRMR $2.24
- SOPH $2.99
- Analyst Decision
- LRMR Strong Buy
- SOPH Strong Buy
- Analyst Count
- LRMR 9
- SOPH 2
- Target Price
- LRMR $19.00
- SOPH $6.50
- AVG Volume (30 Days)
- LRMR 1.4M
- SOPH 26.8K
- Earning Date
- LRMR 04-30-2025
- SOPH 05-06-2025
- Dividend Yield
- LRMR N/A
- SOPH N/A
- EPS Growth
- LRMR N/A
- SOPH N/A
- EPS
- LRMR N/A
- SOPH N/A
- Revenue
- LRMR N/A
- SOPH $67,173,000.00
- Revenue This Year
- LRMR N/A
- SOPH $14.86
- Revenue Next Year
- LRMR N/A
- SOPH $22.76
- P/E Ratio
- LRMR N/A
- SOPH N/A
- Revenue Growth
- LRMR N/A
- SOPH 4.66
- 52 Week Low
- LRMR $1.61
- SOPH $2.58
- 52 Week High
- LRMR $11.20
- SOPH $6.28
- Technical
- Relative Strength Index (RSI)
- LRMR 47.46
- SOPH 47.34
- Support Level
- LRMR $2.03
- SOPH $2.90
- Resistance Level
- LRMR $3.07
- SOPH $3.33
- Average True Range (ATR)
- LRMR 0.30
- SOPH 0.21
- MACD
- LRMR 0.01
- SOPH 0.01
- Stochastic Oscillator
- LRMR 31.12
- SOPH 44.46
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.